Tumour Immunology Workshop Session IV: Cellular engineering and adoptive immunotherapy — ASN Events
  1. Schedule
  2. Monday
  3. Tumour Immunology Workshop Session IV: Cellular engineering and adoptive immunotherapy
1:30PM - 2:35PM
P8
Chair: James Wells

#ASI2017QLD

Targeting local tumour immunosuppression to enhance chimeric antigen receptor T Cell efficacy in solid cancers - Paul A Beavis

Silencing of immunogenic antigens during adoptive cell therapy is an acquired resistance mediated by complex epigenetic mechanisms - Jonathan Chee